Watchlist Price Alert

Recursion Pharmaceuticals... (RXRX)

NASDAQ: RXRX · Real-Time Price · USD

4.16

-0.59 (-12.51%)

At close: May 06, 2025, 3:59 PM

4.30

3.50%

Pre-market: May 07, 2025, 08:25 AM EDT

Recursion Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	594.35M	391.56M	549.91M	285.12M	262.13M	69.88M
Short-Term Investments	n/a	n/a	n/a	231.45M	n/a	n/a
Long-Term Investments	n/a	n/a	7.92M	8.68M	n/a	n/a
Other Long-Term Assets	14.45M	6.89M	7.92M	8.72M	650K	663K
Receivables	49.17M	3.09M	2.75M	9.09M	156K	151K
Inventory	n/a	n/a	1.28M	1.55M	5.04M	5.29M
Other Current Assets	70.75M	43.48M	17.15M	9.07M	2.15M	1.08M
Total Current Assets	714.27M	438.14M	569.81M	534.72M	269.48M	76.4M
Property-Plant & Equipment	233.21M	120.17M	121.45M	64.72M	25.97M	24.37M
Goodwill & Intangibles	484.73M	88.5M	2.11M	2.19M	2.49M	n/a
Total Long-Term Assets	734.33M	215.56M	131.47M	75.63M	29.11M	25.03M
Total Assets	1.45B	653.7M	701.29M	610.35M	298.58M	101.43M
Account Payables	21.61M	3.95M	4.59M	2.82M	1.07M	1.26M
Deferred Revenue	61.77M	36.43M	56.73M	10M	10M	n/a
Short-Term Debt	22.22M	41K	6.05M	1.51M	1.54M	77K
Other Current Liabilities	81.87M	23.75M	14.48M	20.59M	9.53M	2.46M
Total Current Liabilities	187.47M	93.17M	100.27M	46.66M	23.1M	6.68M
Long-Term Debt	19.02M	1.1M	536K	633K	11.41M	12.42M
Other Long-Term Liabilities	190.75M	n/a	n/a	4.11M	450.99M	203.39M
Total Long-Term Liabilities	226.34M	97.09M	115.22M	20.75M	481.77M	219.01M
Total Liabilities	413.82M	190.26M	215.48M	67.41M	504.87M	225.7M
Total Debt	108.49M	50.67M	51.01M	11.48M	15.66M	16.17M
Common Stock	4K	2K	2K	2K	n/a	n/a
Retained Earnings	-1.43B	-967.62M	-639.56M	-400.08M	-213.6M	-126.59M
Comprehensive Income	-7.64M	-0.00	0.00	-126K	n/a	n/a
Shareholders Equity	1.03B	463.44M	485.81M	542.94M	-206.29M	-124.27M
Total Investments	n/a	6.63M	7.92M	231.45M	n/a	n/a